EYPT Financials: EyePoint Inc AI Analysis



Financials

EYPT Financial

EyePoint Inc

$14.38

4.73%

$0.65

At close: Jun 23, 16:00:00 GMT-4

$14.81

2.99%

$0.42

Post-market: Jun 23, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$13.73

Open

$13.62

Day's Range

$13.6 - $14.88

52 week range

$7.94 - $19.11

Volume

Avg.Volume

1.2M

Dividend yield

EPS (TTM)

-3.50

Market Cap

$1.2B

What is EYPT?

EyePoint Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. The company is headquartered in Watertown, Massachusetts and currently employs 214 full-time employees. The company went IPO on 2005-01-27. The firm is focused on developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The Company’s lead product candidate, DURAVYU, is an investigational-sustained delivery treatment for serious retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor, with bioerodible Durasert E technology. Vorolanib features a novel multi-mechanism of action as it targets both vascular endothelial growth factor (VEGF)-mediated vascular permeability and IL-6 mediated inflammation through inhibition of all VEGF receptors and pro-inflammatory IL-6/JAK1 signaling. DURAVYU is in Phase III pivotal trials for wet age-related macular degeneration. DURAVYU is also being advanced for the treatment of diabetic macular edema (DME) with the first patient dosing in Phase III trials.

Features

Markets

News

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
Revenue	7	0	0	0	5	24
Revenue Growth (YoY)	-88%	-100%	-100%	-100%	-44%	118%
Cost of Revenue	1	0	0	0	0	0
Gross Profit	5	0	0	0	5	23
Selling, General & Admin	57	16	12	15	12	14
Research & Development	230	71	58	46	54	57
Operating Expenses	287	87	70	62	67	72
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-271	-84	-67	-59	-59	-45
Income Tax Expense	0	0	0	0	0	--
Net Income	-271	-84	-67	-59	-59	-45
Net Income Growth	86%	87%	63%	103%	97%	55%
Shares Outstanding (Diluted)	85.99	85.99	83.13	70.16	69.92	69.76
Shares Change (YoY)	23%	23%	28.99%	28.99%	31%	32%
EPS (Diluted)	-3.15	-0.98	-0.81	-0.85	-0.84	-0.64
EPS Growth	50%	52%	27%	57.99%	47%	17%
Free Cash Flow	-271	-81	-66	-60	-63	-53
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	71.42%	0%	0%	0%	100%	95.83%
Operating Margin	-4,014.28%	0%	0%	0%	-1,240%	-200%
Profit Margin	-3,871.42%	0%	0%	0%	-1,180%	-187.5%
Free Cash Flow Margin	-3,871.42%	0%	0%	0%	-1,260%	-220.83%
EBITDA	-279	-87	-70	-62	-62	-48
EBITDA Margin	-3,985.71%	0%	0%	0%	-1,240%	-200%
D&A For EBITDA	2	0	0	0	0	0
EBIT	-281	-87	-70	-62	-62	-48
EBIT Margin	-4,014.28%	0%	0%	0%	-1,240%	-200%
Effective Tax Rate	0%	0%	0%	0%	0%	--

Breakdown

TTM

03/31/2026

12/31/2025

09/30/2025

06/30/2025

03/31/2025

Revenue

Revenue Growth (YoY)

-88%

-100%

-44%

118%

Cost of Revenue

Gross Profit

Selling, General & Admin

Research & Development

230

Operating Expenses

287

Other Non Operating Income (Expenses)

Pretax Income

-271

-84

-67

-59

-45

Income Tax Expense

Net Income

-271

-84

-67

-59

-45

Net Income Growth

86%

87%

63%

103%

97%

55%

Shares Outstanding (Diluted)

85.99

83.13

70.16

69.92

69.76

Shares Change (YoY)

23%

28.99%

31%

32%

EPS (Diluted)

-3.15

-0.98

-0.81

-0.85

-0.84

-0.64

EPS Growth

50%

52%

27%

57.99%

47%

17%

Free Cash Flow

-271

-81

-66

-60

-63

-53

Free Cash Flow Per Share

Gross Margin

71.42%

100%

95.83%

Operating Margin

-4,014.28%

-1,240%

-200%

Profit Margin

-3,871.42%

-1,180%

-187.5%

Free Cash Flow Margin

-3,871.42%

-1,260%

-220.83%

EBITDA

-279

-87

-70

-62

-48

EBITDA Margin

-3,985.71%

-1,240%

-200%

D&A For EBITDA

EBIT

-281

-87

-70

-62

-48

EBIT Margin

-4,014.28%

-1,240%

-200%

Effective Tax Rate

Follow-Up Questions

What are EyePoint Inc's key financial statements?



According to the latest financial statement (Form-10K), EyePoint Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for EYPT?



EyePoint Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is EyePoint Inc's revenue broken down by segment or geography?



EyePoint Inc largest revenue segment is Ophthalmic Products, at a revenue of 31,371,000 in the most earnings release.For geography, United States is the primary market for EyePoint Inc, at a revenue of 29,979,000.

Is EyePoint Inc profitable?



no, according to the latest financial statements, EyePoint Inc has a net loss of $0

Does EyePoint Inc have any liabilities?



no, EyePoint Inc has liability of 0

How many outstanding shares for EyePoint Inc?



EyePoint Inc has a total outstanding shares of 0

EyePoint Inc (EYPT) Financial

EYPT Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is EYPT?

EyePoint Inc (EYPT) Financial

EYPT Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is EYPT?

EYPT Income

Follow-Up Questions

What are EyePoint Inc's key financial statements?

What are the key financial ratios for EYPT?

How is EyePoint Inc's revenue broken down by segment or geography?

Is EyePoint Inc profitable?

Does EyePoint Inc have any liabilities?

How many outstanding shares for EyePoint Inc?